⌘K
Loading ticker…
As of 2026-08-24, Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA) has a 3-month relative strength percentile of 64 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 60. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 2.8%, relative volume 0.55×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
TEVA is in a stage 2 uptrend, week 4. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 8.8% / 15.3%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
TEVA is held by 11 ETFs as of May 2026. Top owner: EIS at 8.82% weight, $91M notional. Top 3 carry $142M.
Held by 62 ETFs · $1.1B across latest filings · largest weight 10.35% (ISRA).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| new |
| URTH | 0.05% | $4M | — |
| APIE | 0.12% | $1M | +0.02 pp |
| HRTS | 2.06% | $1M | +0.44 pp |
| PABD | 0.19% | $626K | — |
Showing 10 of 11 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TEVA Jan avg: 5.28% median: 12.38% win: 75% σ: 16.84% n: 4 2022-04-12 → 2026-07-31 | TEVA Feb avg: -1.28% median: -3.31% win: 25% σ: 7.22% n: 4 2022-04-12 → 2026-07-31 | TEVA Mar avg: -5.27% median: -8.66% win: 25% σ: 8.62% n: 4 2022-04-12 → 2026-07-31 | TEVA Apr avg: 0.09% median: -0.43% win: 40% σ: 11.19% n: 5 2022-04-12 → 2026-07-31 | TEVA May avg: 3.27% median: 4.48% win: 80% σ: 13.80% n: 5 2022-04-12 → 2026-07-31 | TEVA Jun avg: -4.20% median: -4.02% win: 20% σ: 8.17% n: 5 2022-04-12 → 2026-07-31 | TEVA Jul avg: 7.81% median: 7.26% win: 80% σ: 11.88% n: 5 2022-04-12 → 2026-07-31 | TEVA Aug avg: 9.95% median: 12.23% win: 75% σ: 10.12% n: 4 2022-04-12 → 2026-07-31 (current) | TEVA Sep avg: -0.21% median: 0.00% win: 50% σ: 9.20% n: 4 2022-04-12 → 2026-07-31 | TEVA Oct avg: -0.41% median: 1.86% win: 75% σ: 11.10% n: 4 2022-04-12 → 2026-07-31 | TEVA Nov avg: 8.77% median: 6.39% win: 50% σ: 17.93% n: 4 2022-04-12 → 2026-07-31 | TEVA Dec avg: 14.43% median: 11.19% win: 100% σ: 12.43% n: 4 2022-04-12 → 2026-07-31 |